Novartis India Limited (BOM:500672)

Market Cap	25.94B +29.1%
Revenue (ttm)	3.48B -1.7%
Net Income	972.30M +12.7%
EPS	39.38 +12.7%
Shares Out	24.69M
PE Ratio	26.68
Forward PE	n/a
Dividend	25.00 (2.41%)
Ex-Dividend Date	Jul 23, 2025

Volume	2,034
Average Volume	7,120
Open	1,046.95
Previous Close	1,038.10
Day's Range	1,035.05 - 1,056.95
52-Week Range	750.00 - 1,099.90
Beta	-0.02
RSI	63.70
Earnings Date	Jan 28, 2026

About Novartis India

Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited operates as a subsidiary of Novartis AG.

• Industry: Pharmaceutical Preparations
• Founded: 1947
• Employees: 56
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500672

Financial Performance

In fiscal year 2025, Novartis India's revenue was 3.56 billion, an increase of 6.33% compared to the previous year's 3.35 billion. Earnings were 1.01 billion, an increase of 18.44%.